Predicting COVID-19 Severity with a Specific Nucleocapsid Antibody plus Disease Risk Factor Score

Effective methods for predicting COVID-19 disease trajectories are urgently needed. Here, enzyme-linked immunosorbent assay (ELISA) and coronavirus antigen microarray (COVAM) analysis mapped antibody epitopes in the plasma of COVID-19 patients (n = 86) experiencing a wide range of disease states. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Sen, Sanjana R., Sanders, Emily C., Gabriel, Kristin N., Miller, Brian M., Isoda, Hariny M., Salcedo, Gabriela S., Garrido, Jason E., Dyer, Rebekah P., Nakajima, Rie, Jain, Aarti, Caldaruse, Ana-Maria, Santos, Alicia M., Bhuvan, Keertna, Tifrea, Delia F., Ricks-Oddie, Joni L., Felgner, Philip L., Edwards, Robert A., Majumdar, Sudipta, Weiss, Gregory A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092137/
https://www.ncbi.nlm.nih.gov/pubmed/33910993
http://dx.doi.org/10.1128/mSphere.00203-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092137/
https://www.ncbi.nlm.nih.gov/pubmed/33910993
http://dx.doi.org/10.1128/mSphere.00203-21

Ejemplares similares